You need to breathe deeply before posting. The pro

You need to breathe deeply before posting. The products they were referring to were the nutraceuticals like CBD tinctures. They can get back into that with their HEMPd brand at any time when it appears to offer greater sales potential. The HEMPd beverages are still being produced and distributed, but big front loaded expansion of ANY kind needs a lot of capital. There are two places for start ups to get that capital. One is diluting shares, unless revenues come in strongly enough to pay off the notes within the 6 month holding period required for GHS, and the other is straight from those revenue streams. That revenue, for acceleration of growth, must come from potential revenue streams offering the least front loading and the least "leaching" of revenue by "middle men". What they are doing now is just smart business. Whether you believe it is or not is your opinion, but you should limit the worst of your bashing to Paul. The only truth in your post is that the financials have not been posted yet to verify revenue growth. The rest is merely flawed speculation based on poor business sense as far as I'm concerned. Maybe you should sell and end your misery as well as your need to bash your own investment with nonsensical business strategies.